Rana Daggubati's fame and popularity did definitely rise to newer heights with the success of the Baahubali series and his portrayal of Bhallaladeva in the movie did win him a lot of praises. He is now shooting for "1945" (pre-Independent war drama - historical), where he plays a soldier in Netaji Subhash Chandra Boseâ€™s Indian National Army. The second movie will be a continuation of Marthanda Varma where the story will be that of the successor of the king. The film has its script penned Robin Thirumala and will be produced by Seven Arts Mohan. It's interesting that the actor is no longer willing to play anything run-of-the-mill and is open to experiment with every new project.
Rana Daggubati is riding high with two hits this year with Baahubali 2: The Conclusion and Nene Raju Nene Mantri.
Arista Networks, Inc. (NYSE:ANET) Upward Momentum Touches New Heights
Finally, Berenberg Bank started coverage on shares of Arista Networks in a research report on Tuesday, September 26th. The Company' divisions include Global Ceramic, Flooring North America and Flooring Rest of the World (Flooring ROW).
Not many lead Telugu actors have made a debut in Malayalam films. Rana will be part of the first film only, as of now. Talking to Times of India, she recently said, "Throughout the film, you'll see me wearing saree with minimal make-up. It's a very nuanced character".
Rana Daggubati himself took to his Twitter account to announce his association with the project. Yuvan Shankar Raja is composing tunes and Sathya cranks the camera.
Great American Smoke Out!!
Joseph Community Health Agency is once again recognizing the American Cancer Society's Great American Smokeout this Thursday. Quitting for just one day is an important step toward a healthier you, especially if that one day can lead to many more.
Rana has also played some notable roles in Bollywood. The film is bankrolled by SN Rajarajan under the banner K Productions.
Advance Auto Parts Inc (AAP): What Are The Future Prospects?
For instance, insider trading is illicit when the trader has special information, which is not available to other shareholders. Taubman Centers, Inc. (NYSE:TCO) has a market cap of $3.27 billion and over the last 12 months, TCO has declined by -25.54%.